Hangzhou Haoyue Personal Care Valuation

Q: What is the Fair Price of 605009 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

605009 (CN¥40.06) is trading above our estimate of [[fair value]] (CN¥4.66)

Is 605009 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 605009 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 605009 (CN¥40.06) is trading above our estimate of fair value (CN¥4.66)

Significantly Below Fair Value: 605009 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 605009?

Key metric: As 605009 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 605009. This is calculated by dividing 605009's market cap by their current earnings.
What is 605009's PE Ratio?
PE Ratio	14.5x
Earnings	CN¥422.90m
Market Cap	CN¥6.14b

605009 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.9x
Enterprise Value/EBITDA	9.1x
PEG Ratio	0.9x

Price to Earnings Ratio vs Peers

How does 605009's PE Ratio compare to its peers?

The above table shows the PE ratio for 605009 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	32.5x
001328 Dencare (Chongqing) Oral Care	34.1x	17.4%	CN¥5.2b
301507 Hangzhou Minsheng Healthcare	53.2x	n/a	CN¥4.8b
300740 SYoung Group	24.1x	23.7%	CN¥5.0b
603896 Zhejiang Shouxiangu Pharmaceutical	18.7x	19.4%	CN¥4.4b
605009 Hangzhou Haoyue Personal Care	14.5x	16.4%	CN¥6.1b

Price-To-Earnings vs Peers: 605009 is good value based on its Price-To-Earnings Ratio (14.5x) compared to the peer average (32.5x).

Price to Earnings Ratio vs Industry

How does 605009's PE Ratio compare vs other companies in the CN Personal Products Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 605009 is good value based on its Price-To-Earnings Ratio (14.5x) compared to the CN Personal Products industry average (33.9x).

Price to Earnings Ratio vs Fair Ratio

What is 605009's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

605009 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	14.5x
Fair PE Ratio	21.9x

Price-To-Earnings vs Fair Ratio: 605009 is good value based on its Price-To-Earnings Ratio (14.5x) compared to the estimated Fair Price-To-Earnings Ratio (21.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

SYoung Group

CN¥5.0b

Engages in the research and development, production, and sale of cosmetic products in China.

300740

CN¥12.95

-6.8%

-21.8%

Byhealth

CN¥21.7b

Develops and sells dietary supplements.

300146

CN¥12.89

-5.0%

-29.8%

Sirio Pharma

CN¥6.4b

Operates as a contract manufacturer for dietary supplement industry worldwide.

300791

CN¥27.36

-3.5%

6.2%